EPHA4 and early-onset autosomal dominant Alzheimer disease: The identification of a protective role for EphA4 reduction in ALS models, along with evidence suggesting EphA4 inhibition could be protective in mouse models of Alzheimer’s disease, spinal cord injury, and stroke3–6, prompted interest in developing EphA4 inhibitors as a potential therapeutic strategy for treating neurodegeneration.